Results 191 to 200 of about 31,861 (267)

Efficacy of anakinra in reducing progression to organ dysfunction in patients with pneumonia (INSPIRE): a randomised, double-blind, placebo-controlled, phase IIa trial. [PDF]

open access: yesLancet Reg Health Eur
Tavoulareas G   +13 more
europepmc   +1 more source

Comparative Efficacy and Safety of Anakinra and Canakinumab in Patients With VEXAS Syndrome: An International Multicenter Study. [PDF]

open access: yesArthritis Rheumatol
Eviatar T   +35 more
europepmc   +1 more source

Juvenile interleukin-36 receptor antagonist deficiency (DITRA) with c.80T>C (p.Leu27Pro) mutation successfully treated with etanercept and acitretin [PDF]

open access: yes, 2018
Cuperus, E.   +6 more
core   +3 more sources

P198 Anti-inflammatory treatment with the IL-1R antagonist anakinra does not aggravate Pseudomonas aeruginosa infection in mice with cystic fibrosis-like lung disease

open access: bronze, 2019
Zhe Zhou-Suckow   +8 more
openalex   +1 more source

IL-1R/IL-6R blockade for null NLRP12 variant-carrying Takayasu arteritis. [PDF]

open access: yesRheumatology (Oxford)
Argyropoulou OD   +5 more
europepmc   +1 more source

The Effects of Anakinra on Cardiorespiratory Fitness in Heart Failure Stratified by Age in Phase II Clinical Trials. [PDF]

open access: yesJ Cardiovasc Pharmacol
Hogwood AC   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy